Hypertension extends maturity dates for a number of its outstanding warrants

By Devika Patel

Knoxville, Tenn., March 19 - Hypertension Diagnostics, Inc. once again extended the deadline for exercising several of its warrants, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company announced in September that it was delaying the expiry of half of its B warrants, which were issued in August 2003. In Wednesday's filing, Hypertension said the remaining warrants will expire on Dec. 31. They had been set to expire on March 31.

The company also said in the filing that its B warrants, which were issued in February 2004 and also were to expire on March 31, now will expire on Dec. 31. Holders who convert at least 50% of their warrants by that deadline may convert the remaining 50% of their warrants through June 30, 2009.

The company's C warrants, which were issued in the 2003 placement, will expire on Sept. 30, 2009, extended from Aug. 28.

Hypertension's C warrants from the 2004 placement now will expire on March 31, 2010, extended from their original deadline of Feb. 9, 2009.

The company also said in the filing it was extending the expiration date of the warrants it issued to Bernard T. Weber to Sept. 30, 2009 from Aug. 28.

Hypertension makes blood pressure waveform analysis equipment and is based in Eagan, Minn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.